Stage I Breast Cancer AJCC v7 Recruiting Phase 2 Trials for Exemestane (DB00990)

IndicationStatusPhase
DBCOND0092280 (Stage I Breast Cancer AJCC v7)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02598557Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast CancerPrevention